A nonmyeloablative chimeric mouse model accurately defines microglia and macrophage contribution in gliomaKenny Yu, Brian Bigger, Ian Kamaly-Asl et al.|Neuropathology and Applied Neurobiology|2018Cited by 24
High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of glioblastomaKenny Yu, Brian Bigger, Jessica Taylor et al.|PLoS ONE|2018Cited by 17
Characterisation of central versus peripheral tumour associated macrophages in glioblastoma multiformeAmir Saam Youshani, Brian Bigger, Kenny Yu et al.|The Lancet|2016Cited by 1
P08.67 Defining brain microglia versus peripheral macrophages in a mouse model of glioblastoma using a non-myeloablative conditioning regimenKenny Yu, Brian Bigger, Amir Saam Youshani et al.|Neuro-Oncology|2017Cited by 0
IMMU-50. A NOVEL CHIMERIC MODEL TO ACCURATELY IDENTIFY TAMMs IN GLIOBLASTOMAAmir Saam Youshani, Brian Bigger, Kenny Yu et al.|Neuro-Oncology|2017Cited by 0